Using biochemical assays to decipher HPVs tumor binding characteristics in vitro, it was noted that heparinase treatment of tumor cells abrogated HPVs binding ability and the same basement membrane-associated HSPG N-, 6-O and 2-O sulfation patterns were responsible for HPV tumor targeting. Here, HSPG2 is linked to neoplasm.